Navigation Links
Transplant Program Tops in Expected One-Year Survival Rate
Date:1/22/2009

SEATTLE, Jan. 22 /PRNewswire/ -- Fred Hutchinson Cancer Research Center's stem-cell transplant program at the Seattle Cancer Care Alliance (SCCA) was one of only two transplant programs nationwide that consistently outperformed the expected one-year survival rate for unrelated donor transplants, according to an independent report that assessed 122 transplant centers over a five-year period.

The Center for International Blood and Marrow Transplant Registry examined the survival rates of 8,847 transplants performed to treat blood cancers at U.S. centers in the National Marrow Donor Program (NMDP) network. The survival data was collected for the years 2002 through 2006 and patient outcomes were measured at the end of 2007. In each of five years, the Hutchinson Center "over performed" in terms of expected one-year survival rates after transplant. Only one other transplant center in the nation matched that record. The data was adjusted for several risk factors that could influence patient outcomes such as type of disease, its stage, patient age and degree of donor cell match.

Stem-cell and bone-marrow transplants are used to treat various leukemias, lymphomas and severe aplastic anemia.

"The study's findings reflect the extraordinary and longtime dedication by the staff of the Hutchinson Center and SCCA to improve the outcomes of our patients by continually refining transplantation to be a safer and more effective treatment," said Fred Appelbaum, M.D., executive director of the SCCA and director of the Hutchinson Center's Clinical Research Division.

The clinical use of bone-marrow and stem-cell transplantation was first developed at the Hutchinson Center and, subsequently, most of its practitioners were trained there. Patients who choose to have their transplants done at centers that do a high number of such procedures generally have better outcomes.

Required by federal law, the registry's annual report is designed to provide potential stem-cell transplant recipients, their families and the public with comparative survival rates among the transplant centers in the NMDP network.

About Seattle Cancer Care Alliance

Seattle Cancer Care Alliance, established in 1998, unites the adult and pediatric cancer-care services of Fred Hutchinson Cancer Research Center, UW Medicine and Children's Hospital and Regional Medical Center. A major focus of SCCA is to speed the transfer of new diagnostic and treatment techniques from the research setting to the patient bedside while providing premier, patient-focused cancer care. Patients who come to SCCA receive the latest research-based cancer therapies as well as cutting-edge treatments for a number of non-malignant diseases under development by its partner organizations. SCCA has three clinical-care sites: an outpatient clinic on the Fred Hutchinson campus, a pediatric-inpatient unit at Children's and an adult-inpatient unit at UW Medical Center. For more information about SCCA, visit http://www.seattlecca.org.

Media Contact:

Dean Forbes, (206) 667-289


'/>"/>
SOURCE Seattle Cancer Care Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program
2. Transplanted cells may hold the key to curing hemophilia A, Einstein scientists report
3. New Independent Research Study Indicates That Cylexs ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection
4. Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection
5. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
6. Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkins Lymphoma
7. Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop Designer Transplants
8. The First Ever Transplantation World-Wide of Entire Arms at the "Klinikum rechts der Isar" in Munich
9. AST Endorses Istanbul Declaration to End Organ Trafficking and Transplant Tourism
10. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
11. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... ... name change to Fluence Analytics. , Fluence Analytics provides proprietary hardware ... biopharmaceutical manufacturing processes and R&D applications. The company’s patented technologies improve production ...
(Date:4/27/2017)... 2017  Pendant Biosciences, Inc. (formerly Nanoferix, Inc.), a ... drug delivery technologies, today announced that it has been ... Toronto . Shawn Glinter ... noted, "We are excited to become part of the ... are honored to be the first Tennessee ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... teamed up with NASA to showcase the future of deep space exploration and ... (SLS) rocket and Orion spacecraft and includes a guest appearance by former Shuttle ...
(Date:4/26/2017)... ... April 26, 2017 , ... Baltimore bio tech firm, ... security screening solution at the National Postal Forum 2017 in Baltimore, Maryland, May ... highly accurate, easy to use and low cost threat detection solution for government ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):